Universe Pharmaceuticals ... (UPC)
Universe Pharmaceuticals INC Statistics
Share Statistics
Universe Pharmaceuticals INC has 8.66M shares outstanding. The number of shares has increased by -42.31% in one year.
| Shares Outstanding | 8.66M |
| Shares Change (YoY) | -42.31% |
| Shares Change (QoQ) | -91.11% |
| Owned by Institutions (%) | 0.47% |
| Shares Floating | 8.09M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 159.9K, so 7.6% of the outstanding shares have been sold short.
| Short Interest | 159.9K |
| Short % of Shares Out | 7.6% |
| Short % of Float | 8.14% |
| Short Ratio (days to cover) | 0.11 |
Valuation Ratios
The PE ratio is -8.38 and the forward PE ratio is null. Universe Pharmaceuticals INC's PEG ratio is 0.28.
| PE Ratio | -8.38 |
| Forward PE | n/a |
| PS Ratio | 1.6 |
| Forward PS | null |
| PB Ratio | 1.31 |
| P/FCF Ratio | 48.01 |
| PEG Ratio | 0.28 |
Enterprise Valuation
Universe Pharmaceuticals INC has an Enterprise Value (EV) of 3.64M.
| EV / Earnings | -0.59 |
| EV / Sales | 0.11 |
| EV / EBITDA | -1.13 |
| EV / EBIT | -1.03 |
| EV / FCF | 3.38 |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.68 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 12.18 |
| Cash Flow / Debt | 0.2 |
| Interest Coverage | -22.49 |
Financial Efficiency
Return on equity (ROE) is -0.16% and return on capital (ROIC) is -12.54%.
| Return on Equity (ROE) | -0.16% |
| Return on Assets (ROA) | -0.12% |
| Return on Capital (ROIC) | -12.54% |
| Revenue Per Employee | $143,594.38 |
| Profits Per Employee | $-27,391.38 |
| Employee Count | 225 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 6.58 |
Taxes
| Income Tax | 2.31M |
| Effective Tax Rate | -0.6 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.41, so Universe Pharmaceuticals INC's price volatility has been higher than the market average.
| Beta | 1.41 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 20.71 |
| Relative Strength Index (RSI) | 26.24 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Universe Pharmaceuticals INC had revenue of 32.31M and earned -6.16M in profits. Earnings per share was -1.7.
| Revenue | 32.31M |
| Gross Profit | 10.32M |
| Operating Income | -3.53M |
| Net Income | -6.16M |
| EBITDA | -3.22M |
| EBIT | -3.53M |
| Earnings Per Share (EPS) | -1.7 |
Balance Sheet
The company has 5.29M in cash and 5.48M in debt, giving a net cash position of -197.21K.
| Cash & Cash Equivalents | 5.29M |
| Total Debt | 5.48M |
| Net Cash | -197.21K |
| Retained Earnings | 10.16M |
| Total Assets | 49.43M |
| Working Capital | 12.92M |
Cash Flow
In the last 12 months, operating cash flow was 1.12M and capital expenditures -44.17K, giving a free cash flow of 1.08M.
| Operating Cash Flow | 1.12M |
| Capital Expenditures | -44.17K |
| Free Cash Flow | 1.08M |
| FCF Per Share | 0.3 |
Margins
Gross margin is 31.93%, with operating and profit margins of -10.92% and -19.08%.
| Gross Margin | 31.93% |
| Operating Margin | -10.92% |
| Pretax Margin | -11.91% |
| Profit Margin | -19.08% |
| EBITDA Margin | -9.95% |
| EBIT Margin | -10.92% |
| FCF Margin | 3.33% |
Dividends & Yields
UPC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for UPC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 18, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | Nov 18, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -0.32 |
| Piotroski F-Score | 1 |